Neki article naslov
October 31, 2024Subheadline naslov
“No matter who they vote for, Americans are suffering from the high costs of prescription drugs,” says Tim Lash, president of West Health, a family of nonprofit organizations focused on reducing healthcare costs and improving quality of care. “The public’s overwhelming support for this policy, even as we head into a presidential election, makes one thing exceedingly clear: people know unfair, anticompetitive behavior when they see it and they want it to stop.”
But pharmaceutical companies are seeking to block the program through lawsuits and other means, despite broad and enduring public support for Medicare’s ability to negotiate lower prices for the nation’s more-than 65 million Medicare enrollees.
Big Pharma’s high drug prices are killing us, fueling a public health and humanitarian crisis of its own.
Cao ovde je nastavak teksta
Related content
Downloads
Neki interesantan dokument
Download
About Article Source
The new public opinion survey on Medicare drug price negotiations was carried out between May 30 and June 6 by Gallup in partnership with West Health. Gallup surveyed 2,145 adults living in all 50 U.S. states and the District of Columbia, All samples are weighted to correct for unequal selection probability and non-response. Post-stratification weighting takes into account gender, age, race, Hispanic ethnicity, education and region. Demographic weighting targets are based on the most recent Current Population Survey figures. The survey carries a margin of error at the 95% confidence level is +2.7 percentage points for response percentages around 50% and is +1.6 percentage points for response percentages around 10% or 90%, design effect included. For reported sub-groups, the margin of error will be larger, typically ranging from ±3.5 to ±6 percentage points.
Want to learn more?
You can learn more in the main deep dive article.
